ACell, Inc. a leading regenerative medicine company, has received additional US FDA clearance for its MicroMatrix device, which describes the concurrent use of MicroMatrix in conjunction with Cytal ...
ACell, Inc. today announced the introduction of two new wound management devices: Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer. These devices are intended for the management of partial- ...
COLUMBIA, Md., Dec. 22, 2020 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company, announced today that it has received CE mark approval for its MicroMatrix®, Cytal® Wound Matrix, and ...
ACell Inc., a regenerative medicine company which operates a manufacturing facility in Columbia, announced Wednesday that it has received additional FDA clearance for its MicroMatrix device, which ...
Line of Reinforcement Devices for Hernia and Abdominal Wall Repair to be Introduced at Canadian Surgery Forum COLUMBIA, Md., Sept. 4, 2019 /PRNewswire/ -- ACell, Inc. and Southmedic today announced ...
COLUMBIA, Md., July 15, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today ...